| Entry |
|
|---|
| Name |
Tifacogin (USAN/INN) |
|---|
| Formula |
C1400H2167N395O422S23
|
|---|
| Exact mass |
32000.3827
|
|---|
| Mol weight |
32021.13
|
|---|
| Sequence |
ADSEEDEEHT IITDTELPPL KLMHSFCAFK ADDGPCKAIM KRFFFNIFTR QCEEFIYGGC
EGNQNRFESL EECKKMCTRD NANRIIKTTL QQEKPDFCFL EEDPGICRGY ITRYFYNNQT
KQCERFKYGG CLGNMNNFET LEECKNICED GPNGFQVDNY GTQLNAVNNS LTPQSTKVPS
LFEFHGPSWC LTPADRGLCR ANENRFYYNS VIGKCRPFKY SGCGGNENNF TSKQECLRAC
KKGFIQRISK GGLIKTKRKR KKQRVKIAYE EIFVKNM |
|---|
| Type |
Peptide |
|---|
| Class |
|
|---|
| Efficacy |
Anticoagulant, Lipoprotein associated coagulation inhibitor |
|---|
| Comment |
recombinant tissue factor pathway inhibitor [HSA: 7035] [KO: K03909]
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01707 Fibrinolytic
D06142 Tifacogin
DG01662 Factor Xa inhibitor
D06142 Tifacogin
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
F3 (CD142, TF)
D06142 Tifacogin (USAN/INN)
F7a
D06142 Tifacogin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
